BioTelemetry, Inc. (NASDAQ:BEAT), announced today the definitive results of the tender offer for LifeWatch AG (SIX:LIFE) which concluded on June 28, 2017. The definitive results show shareholders have tendered 17,848,661 shares of LifeWatch, representing approximately 97% of the total shares outstanding.

BioTelemetry, Inc. (NASDAQ:BEAT), announced today that during the main offer period which ended on June 8, 2017, the preliminary results show shareholders have tendered 15,161,925 shares of LifeWatch AG (SIX:LIFE), representing approximately 82% of the total shares outstanding.

BioTelemetry, Inc. (NASDAQ:BEAT), announced today that LifeWatch’s largest shareholders, including Himalaya TMT Fund, Aevis Victoria SA and Antoine Hubert, pledged support of the Company’s tender offer for all outstanding shares of LifeWatch AG (SIX:LIFE) and have agreed to tender their shares.

BioTelemetry, Inc. (NASDAQ:BEAT), announced today that the Company has increased the price of its previously announced public tender offer for all outstanding shares of LifeWatch AG (SIX:LIFE).

BioTelemetry, Inc. (NASDAQ:BEAT), announced today that, in accordance with the provisions of the Offer Prospectus and at the Company’s request, the Swiss Takeover Board has extended the initial main offer period of the tender offer to acquire all of the shares of LifeWatch AG (SIX:LIFE), which was scheduled to expire at 4:00 p.m. CEST, on May 23, 2017.

BioTelemetry, Inc. (NASDAQ:BEAT), announced today the start of the main offer period of the tender offer to acquire all of the shares of LifeWatch AG (SIX:LIFE).

BioTelemetry, Inc. (NASDAQ:BEAT) announced today that, effective on May 5, 2017, it received early termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”) with respect to its previously announced tender offer to acquire all of the capital stock of LifeWatch AG (SIX:LIFE).

Company Reports Record Quarterly Revenue and Patient Volume

BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2017 earnings on Wednesday, May 3, 2017 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, May 3, 2017. The broadcast will be available through the investor information section of the BioTelemetry website at www.gobio.com.